NCT07895914 Validation of the D-TAP Parental Questionnaire for Early Screening of Pediatric Feeding Disorder in Hospitalized Children Aged 8 to 18 Months
| NCT ID | NCT07895914 |
| Status | Recruiting |
| Phase | — |
| Sponsor | University Hospital, Strasbourg, France |
| Condition | Pediatric Feeding Disorder |
| Study Type | OBSERVATIONAL |
| Enrollment | 100 participants |
| Start Date | 2026-02-06 |
| Primary Completion | 2027-02-06 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
This is an observational study. You will not receive an experimental treatment; researchers will collect data based on your existing condition or standard treatment.
This trial targets 100 participants in total. It began in 2026-02-06 with a primary completion date of 2027-02-06.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
This single-center observational study aims to evaluate the validity of the D-TAP parental questionnaire for early screening of pediatric feeding disorder (PFD) in hospitalized children aged 8 to 18 months. Currently, no standardized screening test is routinely used by all healthcare professionals in France to identify PFD, despite its reported prevalence and potential consequences for child development, family well-being, and healthcare costs. The D-TAP questionnaire will be compared with the Montreal Children's Hospital Feeding Scale. A blinded clinical speech-language pathology assessment of information collected during a semi-structured parental interview will be used to identify signs suggestive of PFD. A total of 100 children will be included. The study will assess the diagnostic performance of the D-TAP questionnaire, identify an optimal screening threshold, and explore whether parents initiate contact with a community-based speech-language therapist within six weeks after being informed of signs suggestive of PFD.
Eligibility Criteria
Inclusion Criteria: * Children aged 8 to 18 months, inclusive, receiving care within the pediatric medical-surgical department at the Hautepierre site. * Children born at or after 37 weeks of gestation. Parents who are French-speaking. * Parents affiliated with a social security or health insurance scheme. * Parents who have agreed to participate in the study. Exclusion Criteria: * Parents who refuse participation. * Children diagnosed with a neurodevelopmental disorder. * Children with oromyofacial malformations. * Children with digestive conditions affecting oral feeding, including esophageal achalasia, esophageal atresia, necrotizing enterocolitis, gastroschisis, Hirschsprung disease, eosinophilic esophagitis, omphalocele, chronic intestinal pseudo-obstruction, or short bowel syndrome. * Children with neurological conditions affecting feeding, including pediatric stroke, spinal muscular atrophy, developmental and epileptic encephalopathies, congenital myopathies, cerebral palsy, CHARGE syndrome, congenital myasthenic syndromes, Prader-Willi syndrome, Rett syndrome, Smith-Lemli-Opitz syndrome, traumatic brain injury, or trisomy. * Children with a history of prolonged hospitalization or invasive care during the neonatal period. * Children currently receiving or previously having received artificial nutrition, whether enteral or parenteral.
Contact & Investigator
Frequently Asked Questions
Who can join the NCT07895914 clinical trial?
This trial is open to participants of all sexes, aged 8 Months or older, up to 18 Months, studying Pediatric Feeding Disorder. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT07895914 currently recruiting?
Yes, NCT07895914 is actively recruiting participants. Contact the research team at Isabelle.TALON@chru-strasbourg.fr for enrollment information.
Where is the NCT07895914 trial being conducted?
This trial is being conducted at Strasbourg, France.
Who is sponsoring the NCT07895914 clinical trial?
NCT07895914 is sponsored by University Hospital, Strasbourg, France. The trial plans to enroll 100 participants.